Barbara Gayle Duncan

Insider Reports History

Location
New York, NY
Signature
/s/ Jeffrey Rona, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Gayle Duncan:

Company Role Class Num Shares Value Price $ Report Date Ownership
HALOZYME THERAPEUTICS, INC. Director Common Stock 19,919 $1,199,522 $60.22 01 May 2025 Direct
Atea Pharmaceuticals, Inc. Director Common Stock 62,750 $176,327 $2.81 20 Jun 2025 Direct
Atea Pharmaceuticals, Inc. Director Restricted Stock Units 0 $103,162 $3.49 20 Jun 2025 Direct
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 500,000 01 Jul 2022 Direct
Ovid Therapeutics Inc. Director Employee Stock Option (Right to Buy) 65,000 26 Feb 2026 Direct
Ovid Therapeutics Inc. Director Stock Option (right to buy) 45,000 20 Feb 2025 Direct
Atea Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 41,200 20 Jun 2025 Direct
Fusion Pharmaceuticals Inc. Director Stock Opion (Right to Buy) 17,000 14 Jun 2023 Direct
HALOZYME THERAPEUTICS, INC. Director Option to Purchase Common Stock 5,750 01 May 2025 Direct
Fusion Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 04 Jun 2024 Direct
Jounce Therapeutics, Inc. Director Stock Option (Right to Buy) 0 03 May 2023 Direct

Insider Reports Filed by Barbara Gayle Duncan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OVID Ovid Therapeutics Inc. 26 Feb 2026 1 $0 4 Director 02 Mar 2026, 16:30
AVIR Atea Pharmaceuticals, Inc. 20 Jun 2025 4 $0 4 Director 24 Jun 2025, 18:05
HALO HALOZYME THERAPEUTICS, INC. 01 May 2025 2 $0 4 Director 02 May 2025, 16:04
OVID Ovid Therapeutics Inc. 20 Feb 2025 1 $0 4 Director 18 Jun 2025, 16:45
OVID Ovid Therapeutics Inc. 12 Dec 2024 1 $0 4 Director 16 Dec 2024, 16:15
AVIR Atea Pharmaceuticals, Inc. 21 Jun 2024 2 $0 4 Director 21 Jun 2024, 18:12
AVIR Atea Pharmaceuticals, Inc. 16 Jun 2024 2 $0 4 Director 18 Jun 2024, 17:00
/report/000095017024068885-duncan-barbara-gayle-2024-06-04 Fusion Pharmaceuticals Inc. 04 Jun 2024 4 $0 4 Director 04 Jun 2024, 17:22
HALO HALOZYME THERAPEUTICS, INC. 25 Apr 2024 2 $0 4 Director 29 Apr 2024, 17:54
OVID Ovid Therapeutics Inc. 22 Feb 2024 1 $0 4 Director 26 Feb 2024, 17:54
AVIR Atea Pharmaceuticals, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 16:05
/report/000120919123037091-duncan-barbara-gayle-2023-06-14 Fusion Pharmaceuticals Inc. 14 Jun 2023 1 $0 4 Director 14 Jun 2023, 17:06
HALO HALOZYME THERAPEUTICS, INC. 05 May 2023 2 $0 4 Director 09 May 2023, 18:16
/report/000164045523000108-duncan-barbara-gayle-2023-05-03 Jounce Therapeutics, Inc. 03 May 2023 7 $0 4 Director 04 May 2023, 07:43
OVID Ovid Therapeutics Inc. 23 Feb 2023 1 $0 4 Director 27 Feb 2023, 15:47
HALO HALOZYME THERAPEUTICS, INC. 03 Feb 2023 1 $0 4 Director 07 Feb 2023, 15:06
HALO HALOZYME THERAPEUTICS, INC. 03 Feb 2023 0 $0 3 Director 06 Feb 2023, 16:19
ADAP Adaptimmune Therapeutics PLC 01 Jul 2022 1 $0 4 Director 01 Jul 2022, 17:01
/report/000164045522000069-duncan-barbara-gayle-2022-06-24 Jounce Therapeutics, Inc. 24 Jun 2022 1 $0 4 Director 28 Jun 2022, 21:02
AVIR Atea Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 19:49
/report/000120919122038769-duncan-barbara-gayle-2022-06-14 Fusion Pharmaceuticals Inc. 14 Jun 2022 1 $0 4 Director 22 Jun 2022, 19:07
OVID Ovid Therapeutics Inc. 08 Apr 2022 1 $0 4 Director 12 Apr 2022, 16:55
OVID Ovid Therapeutics Inc. 03 Feb 2022 1 $0 4 Director 04 Feb 2022, 19:48
ADAP Adaptimmune Therapeutics PLC 01 Jul 2021 1 $0 4 Director 02 Jul 2021, 17:00
/report/000164045521000110-duncan-barbara-gayle-2021-06-18 Jounce Therapeutics, Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 16:45
AVIR Atea Pharmaceuticals, Inc. 18 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:35
OVID Ovid Therapeutics Inc. 11 Jun 2021 1 $0 4 Director 11 Jun 2021, 20:31
/report/000120919121038570-duncan-barbara-gayle-2021-06-04 Fusion Pharmaceuticals Inc. 04 Jun 2021 1 $0 4 Director 07 Jun 2021, 16:14
OVID Ovid Therapeutics Inc. 17 May 2021 1 $0 4 Director 18 May 2021, 20:57